At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SXTP 60 degrees pharmaceuticals, Inc.
Market Closed 07-10 16:00:00 EDT
1.56
+0.00
0.00%
盘后1.47
-0.09-5.77%
18:05 EDT
High1.61
Low1.49
Vol17.67K
Open1.61
D1 Closing1.56
Amplitude7.56%
Mkt Cap4.15M
Tradable Cap3.88M
Total Shares2.66M
T/O27.35K
T/O Rate0.71%
Tradable Shares2.49M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-borne Diseases
60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-free Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement With Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized With Babesiosis
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is based in Washington, District Of Columbia.